이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Agilent Technologies 관리

관리 기준 확인 4/4

Agilent Technologies' CEO는 Mike McMullen, Sep2014 에 임명되었습니다 의 임기는 9.5 년입니다. 총 연간 보상은 $ 16.02M, 8.2% 로 구성됩니다. 8.2% 급여 및 91.8% 보너스(회사 주식 및 옵션 포함). 는 MX$ 596.91M 가치에 해당하는 회사 주식의 0.086% 직접 소유합니다. 596.91M. 경영진과 이사회의 평균 재임 기간은 각각 6.8 년과 8.5 년입니다.

주요 정보

Padraig McDonnell

최고 경영자

US$3.3m

총 보상

CEO 급여 비율	18.5%
CEO 임기	less than a year
CEO 소유권	0.01%
경영진 평균 재임 기간	4.6yrs
이사회 평균 재임 기간	7.5yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Padraig McDonnell 의 보수는 Agilent Technologies 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Apr 30 2024	n/a	n/a	US$1b
Jan 31 2024	n/a	n/a	US$1b
Oct 31 2023	US$3m	US$606k	US$1b
Jul 31 2023	n/a	n/a	US$1b
Apr 30 2023	n/a	n/a	US$1b
Jan 31 2023	n/a	n/a	US$1b
Oct 31 2022	n/a	n/a	US$1b
Jul 31 2022	n/a	n/a	US$1b
Apr 30 2022	n/a	n/a	US$1b
Jan 31 2022	n/a	n/a	US$1b
Oct 31 2021	US$3m	US$495k	US$1b

보상 대 시장: Padraig 의 총 보상 ($USD 3.27M ) MX 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 5.86M ).

보상과 수익: Mike 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Padraig McDonnell

less than a year

테뉴어

US$3,272,898

보상

Mr. Padraig McDonnell serves as its CEO, President & Director since May 01, 2024. He served as Senior Vice President at Agilent Technologies, Inc. since May 1, 2020 until February 2024 and served as Chief...

리더십 팀

이름	위치	테뉴어	보상	소유권
Padraig McDonnell	CEO, President & Director	less than a year	US$3.27m	0.0096% $ 66.5m
Robert McMahon	Senior VP & CFO	5.8yrs	US$4.81m	0.032% $ 220.3m
Henrik Ancher-Jensen	Senior VP and President of Order Fulfillment & Supply Chain	10.8yrs	US$3.33m	0.028% $ 195.8m
Rodney Gonsalves	Principal Accounting Officer	9.1yrs	데이터 없음	0.0073% $ 50.7m
John Kohl	Senior Vice President & Chief Information Officer	8.4yrs	데이터 없음	데이터 없음
P. Chiu	VP, Interim General Counsel & Secretary	less than a year	데이터 없음	데이터 없음
Dominique Grau	Senior Vice President of Human Resources & Global Communications	9.8yrs	US$2.21m	0.026% $ 182.5m
Yvonne Mackie	MD of UK & Ireland Operations and VP of Human Resources - Europe	19.4yrs	데이터 없음	데이터 없음
Jenipher Dalton	Senior VP	3.5yrs	데이터 없음	데이터 없음
Philip Binns	Senior VP of Agilent and President of Life Sciences & Applied Markets Group	less than a year	데이터 없음	0.0014% $ 10.0m
Jonah Kirkwood	Senior Vice President	less than a year	데이터 없음	데이터 없음
Angelica Riemann	Senior Vice President	less than a year	데이터 없음	0.0057% $ 39.6m

4.6yrs

평균 재임 기간

58.5yo

평균 연령

경험이 풍부한 관리: A * 의 관리팀은 경험 ( 4.6 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Padraig McDonnell	CEO, President & Director	less than a year	US$3.27m	0.0096% $ 66.5m
Heidi Fields	Independent Director	24.3yrs	US$331.85k	0% $ 0
Otis Brawley	Independent Director	2.6yrs	US$331.85k	0% $ 0
George Scangos	Independent Director	13.4yrs	US$351.85k	0.0062% $ 42.6m
Dow Wilson	Independent Director	6.3yrs	US$356.85k	0% $ 0
Boon Hwee Koh	Independent Non-Executive Chairman	21.1yrs	US$486.85k	0.021% $ 142.7m
Daniel Podolsky	Independent Director	8.9yrs	US$341.85k	0% $ 0
Mala Anand	Independent Director	5.3yrs	US$331.85k	0.0044% $ 30.2m
Mikael Dolsten	Independent Director	2.8yrs	US$341.85k	0.0020% $ 13.6m
Susan Rataj	Independent Director	8.8yrs	US$341.85k	0.0091% $ 63.1m

7.5yrs

평균 재임 기간

67yo

평균 연령

경험이 풍부한 이사회: A * 의 이사회는 경험(평균 재직 기간 8.5 년)으로 간주됩니다.

Agilent Technologies 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Recent updates

Second quarter dividend of US$0.24 announced

Agilent Technologies, Inc. Is Introducing Two New Products At the 72Nd Asms Conference on Mass Spectrometry and Allied Topics

Agilent Technologies, Inc. Provides Financial Guidance for the Third Quarter of Fiscal 2024 and Revises Financial Guidance for the Full Year of Fiscal 2024

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Hans E. Bishop Stepped Down from Board of Directors

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on July 24, 2024

Agilent Technologies, Inc. to Report Q2, 2024 Results on May 29, 2024

Agilent Announces the NovoCyte Opteon, A Cutting-Edge Spectral Flow Cytometry Solution

Agilent Technologies, Inc. Appoints Simon May as President of the Diagnostics and Genomics Group, Effective May 6, 2024

Agilent Technologies, Inc. At AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics

Agilent Technologies Inc. Launches New Advanced Dilution System to Increase Lab Efficiency

Agilent Technologies, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Agilent Technologies, Inc. Announces CEO Changes, effective May 1, 2024

Agilent Technologies, Inc. Announces Quarterly Dividend, Payable on April 24, 2024

Agilent Technologies, Inc. to Report Q1, 2024 Results on Feb 27, 2024

Agilent Technologies, Inc. Announces New Proteoanalyzer System

Agilent Technologies, Inc., Annual General Meeting, Mar 14, 2024

Agilent Makes Strategic Updates to Organizational Structure

Agilent Technologies Inc. Announces the Addition of Water Immersion and New Confocal Spinning Disk Technology to the Biotek Cytation C10 Confocal Imaging Reader

Agilent Technologies, Inc. Provides Earnings Guidance for the First Quarter and Fiscal Year 2024

Agilent Technologies Inc. Increases Quarterly Cash Dividend, Payable on January 24, 2024

Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Agilent Technologies, Inc. Announces Resignation of Sam Raha as Senior Vice President of the Company and President of the Diagnostics and Genomics Group

Agilent Technologies, Inc. to Report Q4, 2023 Results on Nov 20, 2023

Agilent Technologies, Inc. Announces Quarter Dividend, Payable on October 25, 2023

Exact Sciences Corporation (NasdaqCM:EXAS) agreed to acquire Resolution Bioscience, Inc. from Agilent Technologies, Inc. (NYSE:A).

Agilent Technologies, Inc. Announces Management Changes

Agilent Technologies, Inc. Appoints Philip Binns as President of Life Sciences and Applied Markets Group

Agilent Technologies, Inc. Provides Earnings Guidance for the Year 2023

Agilent Technologies, Inc. to Report Q3, 2023 Results on Aug 15, 2023

Agilent Technologies Inc. Announces the Launch of New Gen6 Software for All Agilent BioTek Detection Instruments

Agilent Technologies Inc. Introduces New Comprehensive GPC/SEC Solutions At HPLC 2023 Conference

Agilent Announces Biotek 406 Fx Washer Dispenser for Technology-Driven Workflow Efficiency

Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Full Year Ended 2023

Agilent Technologies, Inc. Announces Cash Dividend, Payable on July 26, 2023

Upcoming dividend of US$0.23 per share at 0.7% yield

First quarter 2023 earnings released: EPS: US$1.19 (vs US$0.94 in 1Q 2022)

Agilent Technologies Inc. Announces New NovoCyte Flow Cytometer System Software for 21 CFR Part 11 Compliance

Agilent Technologies, Inc., Annual General Meeting, Mar 15, 2023

Agilent Technologies, Inc. to Report Q1, 2023 Results on Feb 28, 2023

Agilent Technologies, Inc. (NYSE:A) announces an Equity Buyback for $2,000 million worth of its shares.

Agilent Technologies, Inc. (NYSE : A) acquired Avida Biomed Inc.

Upcoming dividend of US$0.23 per share

Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021)

Insider recently sold Mex$90m worth of stock

Agilent Technologies, Inc.'s ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer

Independent Non-Executive Chairman recently sold Mex$39m worth of stock

Insider recently sold Mex$38m worth of stock

Principal Accounting Officer recently sold Mex$14m worth of stock

Full year 2022 earnings released: EPS: US$4.19 (vs US$3.98 in FY 2021)

Agilent Technologies, Inc. Provides Revenue Guidance for the First Quarter and Year Full Year 2023

Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on January 25, 2023

Agilent Announces AssayMAP Bravo Protein Sample Prep Workbench 4.0

Agilent Technologies, Inc. to Report Q4, 2022 Results on Nov 21, 2022

Agilent Technologies Inc. Announces Release of its Enhanced 8700 LDIR Chemical Imaging System for Microplastics Analysis

Insider recently sold Mex$5.3m worth of stock

Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on October 26, 2022

Insider recently sold Mex$6.7m worth of stock

Third quarter 2022 earnings released: EPS: US$1.10 (vs US$0.87 in 3Q 2021)

Agilent Technologies, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Agilent Technologies, Inc. (NYSE:A) acquired PSS Polymer Standards Service GmbH.

Agilent Technologies, Inc. to Report Q3, 2022 Results on Aug 16, 2022

Insider recently sold Mex$2.4m worth of stock

Upcoming dividend of US$0.21 per share

Insider recently sold Mex$15m worth of stock

Agilent Technologies, Inc. Announces New Oligonucleotide Analysis Software for Biopharma Research

Agilent Technologies, Inc. Releases IVDR-Compliant Instruments, Kits, and Reagents for Use in the European Union

Second quarter 2022 earnings released: EPS: US$0.92 (vs US$0.71 in 2Q 2021)

Agilent Technologies, Inc. Provides Earnings Guidance for the Third Quarter and Fiscal Year 2022